Popular Articles

Embryology Study Offers Clues To Birth Defects
Gregg Duester, Ph.D., professor of developmental biology at Burnham Institute for Medical Research (Burnham), along with Xianling Zhao, Ph.D., and colleagues, have clarified the role that retinoic acid plays in limb development. The study showed that retinoic acid controls the development (or budding) of forelimbs, but not hindlimbs, and that retinoic acid is not responsible for patterning (or differentiation of the parts) of limbs. This research corrects longstanding misconceptions about limb development and provides new insights into congenital limb defects. The study was published online in the journal Current Biology on May 21.

FDA Issues Complete Response Letter For INTUNIV™ (guanfacine) Extended Release For The Treatment Of ADHD In Children And Adolescents
Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces that it has received a Complete Response letter for INTUNIV TM (guanfacine) Extended Release from the Food and Drug Administration (FDA). This decision comes following labeling discussions with the FDA that did not result in agreement in time to meet the PDUFA date.
News of the day
Sunwin International Increases Availability Of Two Veterinary Medicines To Combat Swine Flu Virus In China
Sunwin International Neutraceuticals, Inc. (OTCBB: SUWN), a leader in the production and distribution of Chinese herbs, veterinary medicines and one of the world"s leading producers of all natural, zero calorie Stevia in China, announced today that the company has increased the availability of two veterinary medicines, Huangqiduotang vaccine and Jinfang Detoxification Powder to treat swine flu that has recently spread in North America and other parts of the world. These products, currently used for controlling various types of influenza in China, have demonstrated effectiveness in controlling swine flu outbreaks among livestock.
Diagnostics

General Practices Need More Nurses, Australia

Boosting the number of practice nurses who work with GPs would help improve patient access to care, the AMA said today. AMA Federal President, Dr Andrew Pesce, today used GP Week to renew calls for the Government to increase support for nurses who work in general practices. A recent report funded by the Australian Primary Health Care Research Institute found practice nurses helped take pressure off GPs and increased access to care for patients. "Delegating some tasks to practice nurses frees up GPs to spend more time with patients. Practice nurses are able to perform a range of clinical tasks on behalf of doctors in areas such as diabetes and complex and chronic disease management and preventive screening," Dr Pesce said. "There are currently 8000 Practice nurses employed in around 65% of General Practices. The AMA believes every General Practice should be able to employ a practice nurse. "Only general practices in rural, regional and outer suburban practices are eligible for government general practice nurse subsidies. Removing these geographic restrictions would enable more practices to employ nurses. "The Government should also expand the scope of tasks nurses can perform on behalf of doctors under the Medicare Benefits Schedule (MBS)." Australian Medical Association


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):